Magdalena Winiarska

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Randomized Controlled Trial

Decision Making

Pluripotent Stem Cells

Top Venues

Cancer immunology, immunotherapy : CII

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Malgorzata Bobrowicz, Aleksandra Kusowska, Marta Krawczyk, Andriy Zhylko, Christopher Forcados, Aleksander Slusarczyk, Joanna Barankiewicz, Joanna Domagala, Matylda Kubacz, Michal Šmída, Lenka Dostalova, Katsiaryna Marhelava, Klaudyna Fidyt, Monika Pepek, Iwona Baranowska, Anna Szumera-Cieckiewicz, Else Marit Inderberg, Sébastien Wälchli, Monika Granica, Agnieszka Graczyk-Jarzynka, Martyna Majchrzak, Marcin Poreba, Carina Lynn Gehlert, Matthias Peipp, Malgorzata Firczuk, Monika Prochorec-Sobieszek, Magdalena Winiarska
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies. Oncoimmunology 13 (1) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Malgorzata Bobrowicz, Aleksandra Kusowska, Marta Krawczyk, Andriy Zhylko, Christopher Forcados, Aleksander Slusarczyk, Joanna Barankiewicz, Joanna Domagala, Matylda Kubacz, Michal Šmída, Lenka Dostalova, Katsiaryna Marhelava, Klaudyna Fidyt, Monika Pepek, Iwona Baranowska, Anna Szumera-Cieckiewicz, Else Marit Inderberg, Sébastien Wälchli, Monika Granica, Agnieszka Graczyk-Jarzynka, Martyna Majchrzak, Marcin Poreba, Carina Lynn Gehlert, Matthias Peipp, Malgorzata Firczuk, Monika Prochorec-Sobieszek, Magdalena Winiarska
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies. Oncoimmunology 13 (1) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska, Radoslaw Zagożdżon, Pawel Wisniewski
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo. Cancer immunology, immunotherapy : CII 73 (2) (2024)
Malgorzata Bajor, Agnieszka Graczyk-Jarzynka, Katsiaryna Marhelava, Anna Burdzinska, Angelika Muchowicz, Agnieszka Goral, Andriy Zhylko, Karolina Soroczynska, Kuba Retecki, Marta Krawczyk, Marta Klopotowska, Zofia Pilch, Leszek Paczek, Karl-Johan Malmberg, Sébastien Wälchli, Magdalena Winiarska, Radoslaw Zagożdżon
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells. Journal for immunotherapy of cancer 10 (1) (2022)